Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartmann

Showing results (501-510 of 626) with videos related to

Pageof 63
Sort By:
Annals of Surgical Oncology|June 23, 2010
Pseudoangiomatous stromal hyperplasia and breast cancer riskAmy C Degnim, Marlene H Frost, Derek C Radisky, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Journal of the National Cancer Institute|February 7, 1990
Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphomaL A VanderMolen, R G Steis, P L Duffey, et al.
Breast Cancer Research and Treatment|September 24, 2009
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaMarta Santisteban, Carol Reynolds, Emily G Barr Fritcher, et al.
Journal of the National Cancer Institute|August 2, 1989
Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patientsL C Hartmann, W J Urba, R G Steis, et al.
Genes, Chromosomes & Cancer|July 6, 2004
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriersCamilo Adem, Cheryl L Soderberg, Kari Hafner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profilesFrank De Smet, Nathalie L M M Pochet, Bart L R De Moor, et al.
Annals of Internal Medicine|June 20, 1998
Increased risk for cancer in patients with the Peutz-Jeghers syndromeL A Boardman, S N Thibodeau, D J Schaid, et al.
Oncogene|February 22, 2007
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19qB Tews, P Roerig, C Hartmann, et al.
Pageof 63

Showing results (501-510 of 626) with videos related to

Sort By:
Pageof 63
Annals of Surgical Oncology|June 23, 2010
Pseudoangiomatous stromal hyperplasia and breast cancer riskAmy C Degnim, Marlene H Frost, Derek C Radisky, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Journal of the National Cancer Institute|February 7, 1990
Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphomaL A VanderMolen, R G Steis, P L Duffey, et al.
Breast Cancer Research and Treatment|September 24, 2009
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaMarta Santisteban, Carol Reynolds, Emily G Barr Fritcher, et al.
Journal of the National Cancer Institute|August 2, 1989
Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patientsL C Hartmann, W J Urba, R G Steis, et al.
Genes, Chromosomes & Cancer|July 6, 2004
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriersCamilo Adem, Cheryl L Soderberg, Kari Hafner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profilesFrank De Smet, Nathalie L M M Pochet, Bart L R De Moor, et al.
Annals of Internal Medicine|June 20, 1998
Increased risk for cancer in patients with the Peutz-Jeghers syndromeL A Boardman, S N Thibodeau, D J Schaid, et al.
Oncogene|February 22, 2007
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19qB Tews, P Roerig, C Hartmann, et al.
Pageof 63